HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margaret Bradbury Selected Research

Olivopontocerebellar Atrophies (Olivopontocerebellar Atrophy)

11/2021ATH434 Reduces α-Synuclein-Related Neurodegeneration in a Murine Model of Multiple System Atrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Margaret Bradbury Research Topics

Disease

2Tardive Dyskinesia
01/2021 - 01/2020
2Chorea (Rheumatic Chorea)
01/2021 - 01/2020
2Huntington Disease (Huntington's Disease)
01/2021 - 01/2020
1Olivopontocerebellar Atrophies (Olivopontocerebellar Atrophy)
11/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2021
1Multiple System Atrophy
11/2021
1Synucleinopathies
11/2021
1Parkinson Disease (Parkinson's Disease)
10/2018
1Substance-Related Disorders (Drug Abuse)
08/2009
1Narcolepsy
08/2009
1Sepsis (Septicemia)
03/2009

Drug/Important Bio-Agent (IBA)

1ATH434IBA
11/2021
1SynucleinsIBA
11/2021
1deutetrabenazineIBA
01/2021
1Tetrabenazine (Nitoman)FDA Link
01/2021
1Pharmaceutical PreparationsIBA
01/2020
1Levodopa (L Dopa)FDA LinkGeneric
10/2018
1Dopamine (Intropin)FDA LinkGeneric
10/2018
1NeuropeptidesIBA
08/2009
1OrexinsIBA
08/2009
1Messenger RNA (mRNA)IBA
03/2009
1Granzymes (Granzyme)IBA
03/2009
1Serine Proteases (Serine Protease)IBA
03/2009

Therapy/Procedure

1Therapeutics
03/2009